Dyslipidemia Treatment in India
- Top Accredited Hospitals
- Global Medical Standards
- Cutting-Edge Technology
- Proven Treatment Options
- High Success Rate
- Trusted by Millions
What is Dyslipidemia?
Dyslipidemia is a condition in which one or more types of fats or lipoproteins in the blood are present at abnormal levels. These may include elevated low-density lipoprotein cholesterol (LDL-C), elevated triglycerides, low high-density lipoprotein cholesterol (HDL-C), elevated non-HDL cholesterol, or increased lipoprotein(a) [Lp(a)]. Dyslipidemia can increase the risk of atherosclerotic cardiovascular disease (ASCVD), including heart attack and stroke. Some lipid abnormalities are inherited, while others are linked to diet, obesity, diabetes, kidney disease, thyroid disorders, medications, or other medical conditions.
What is the Importance of Timely Treatment?
Timely diagnosis and management of dyslipidemia can reduce long-term exposure to atherogenic lipoproteins and lower the risk of cardiovascular complications. Dyslipidemia often causes no noticeable symptoms, so routine lipid testing and overall cardiovascular risk assessment are important. Treatment may involve lifestyle changes, statins, other lipid-lowering medicines, and management of underlying conditions.
What are the Common Symptoms of Dyslipidemia?
- Yellowish cholesterol deposits around the eyes or eyelids
- Tendon xanthomas or firm cholesterol deposits in tendons
- Xanthelasma
- Corneal arcus, particularly at a younger age
- Symptoms of cardiovascular disease caused by long-standing lipid abnormalities
- Abdominal pain or other symptoms in severe hypertriglyceridemia, particularly when pancreatitis develops
Causes and Risk Factors of Dyslipidemia
Causes
- Dyslipidemia may result from inherited genetic abnormalities, lifestyle factors, medical conditions, or medicines.
- Common contributors include diets high in saturated fats, excess body weight, physical inactivity, diabetes, hypothyroidism, chronic kidney disease, liver disease, and certain medicines.
- Familial hypercholesterolemia and other inherited lipid disorders can cause markedly elevated cholesterol levels from an early age.
Risk Factors
- Family history of high cholesterol or premature cardiovascular disease
- Unhealthy dietary patterns, particularly high intake of saturated or trans fats
- Physical inactivity
- Overweight or obesity
- Type 2 diabetes or insulin resistance
- Metabolic syndrome
- Hypothyroidism
- Chronic kidney disease
- Liver disease
- Certain hormonal or metabolic disorders
- Smoking
- Excessive alcohol intake, particularly in hypertriglyceridemia
- Certain medicines
- Familial hypercholesterolemia or other inherited lipid disorders
- Increasing age
- Previous cardiovascular disease
Latest Research and Technologies in the Treatment of Dyslipidemia in India
- Current dyslipidemia management focuses on the overall burden of cholesterol-carrying particles in the blood rather than looking at traditional bad cholesterol alone. Modern clinical guidelines evaluate a broad range of blood fats, including triglycerides and specialised proteins like lipoprotein(a), to calculate a person's exact, long-term risk of heart disease and stroke. While healthy lifestyle changes and foundational medications like statins remain the baseline, doctors routinely use advanced risk calculators and heart scans to personalise care.
Treatment options for Dyslipidemia
Sleeve gastrectomy : It is a highly effective treatment for managing lipid disorders, leading to a complete resolution or significant improvement of dyslipidemia. The surgery achieves its metabolic impact mainly through substantial weight loss and a severe reduction in calorie intake, which lowers systemic insulin resistance and reduces the liver's overproduction of triglycerides.
Cost Start From 4500Explore Options
- Clinical assessment:
- Medical and Family History: Evaluation includes dietary habits, physical activity, body weight, smoking, alcohol intake, medications, previous lipid results, diabetes, kidney or thyroid disease, liver disease, cardiovascular history, and family history of high cholesterol or premature ASCVD.
- Physical Examination: Examination may assess blood pressure, body weight, waist circumference, cardiovascular findings, and physical signs of severe lipid disorders.
- Lipid Profile Assessment: A lipid panel generally evaluates total cholesterol, LDL-C, HDL-C, and triglycerides. Non-HDL cholesterol can provide additional information about atherogenic lipoproteins and is particularly useful when triglycerides are elevated.
- Cardiovascular Risk Assessment: Assess overall ASCVD risk using clinical history and appropriate risk-prediction tools.
- Advanced Lipid Testing: Lp(a) measurement is recommended at least once in adulthood, while apoB may be useful in selected patients, particularly when triglycerides are elevated, diabetes is present, or residual cardiovascular risk needs further clarification.
- Assessment of Secondary Causes: Blood tests may be performed to identify conditions that can contribute to dyslipidemia, including diabetes, hypothyroidism, kidney disease, liver disease, and other metabolic disorders.
- Imaging Tests:
- Coronary Artery Calcium (CAC) Scoring: CT-based CAC scoring may be considered in selected adults when the need for preventive lipid-lowering treatment remains uncertain after clinical risk assessment.
- Carotid Ultrasound: Consider in selected patients when assessing vascular disease is clinically relevant, although it is not routinely required for all patients with dyslipidemia.
- Echocardiography: Consider when symptoms or findings suggest structural or functional heart disease.
- CT Coronary Angiography: Consider when clinically indicated for suspected coronary artery disease, rather than as a routine dyslipidemia test.
- Additional Imaging: Recommend vascular imaging, stress testing, or other cardiovascular investigations based on symptoms, cardiovascular risk, and suspected complications.
MediRehab (a chain of Rehab centres, part of MediGence) provides comprehensive rehabilitation services designed to support Dyslipidemia patients in India. These Services include:
- Exercise and Physical Activity: Regular aerobic and resistance exercise can support healthy lipid levels, cardiovascular fitness, weight management, and overall cardiovascular health.
- Cardiovascular Rehabilitation: Patients with established cardiovascular disease may benefit from structured cardiac rehabilitation incorporating exercise, education, nutrition, and risk-factor management.
- Select dyslipidemia medications based on the specific lipid abnormality and the patient's cardiovascular risk. Statins remain the foundation of LDL-C-lowering therapy for many patients requiring medication. If LDL-C remains above the appropriate treatment goal despite lifestyle measures and maximally tolerated statin therapy, consider additional medicines. Other therapies may be used for selected patients with severe hypertriglyceridemia or inherited lipid disorders.
Instantly Connect with our Specialists
Hospitals for Dyslipidemia in India
Aakash Healthcare Super Speciality Hospital
Delhi, India
Aakash Healthcare Super Speciality Hospital located in New Delhi, India is accredited by NABH. Also listed below are some of the most prominent infrastructural details:
- One of the biggest tertiary care hospitals in India
- Facility is fusion of state of the art technology, competent clinicians, and world-class infrastructure
- 230 beds
- 70 bedded medical and surgical and Critical Care Unit
- Ward Bed Options- Twin, Deluxe, Sharing and Economy
- Pneumatic Tube System
- Ambulance Services 24x7
- 15 Bedded dialysis unit
- Advanced Neonatal ICU
- Advanced imaging services, including magnetic resonance imaging, computed tomography scanning, digital mammography, ultrasound
- 8 modular OTs
- Flat Panel Cath Labs
- LASIK - SMILE Suite
- Wellness Lounge
- State-of-the-art diagnostic equipment
- 15 Dialysis beds
- 24x7 ‘Trauma & Emergency Center
- Dedicated blood bank
- 24x7 comprehensive patient care.
- Deployed high-end technologies & smart digital system
- Robust Hospital Information Systems to meet complex medical needs of patients
- Robotic assisted surgeries
- International Patients Lounge
- Airport Pick-up and Drop
- Accommodation and Food for Attendant
- Language Interpreter Services
- 4 triage beds, a dedicated sample collection room, 6 observation beds, and highly skilled emergency staff
- Robotic knee replacement surgery
- ATM
- Lounge for visitors
- Internet Access: The whole facility is Wi-Fi enabled
- Travel Desk: Provides an all-round patient care.
- 24x7 pharmacy
Pushpawati Singhania Research Institute
Delhi, India
Pushpawati Singhania Research Institute located in New Delhi, India is accredited by NABH, NABL. Also listed below are some of the most prominent infrastructural details:
- Multi-bed hospital with state-of-art infrastructure
- Advanced medical equipment
- High-tech labs
- Modular operation theaters
- Cath labs with Clarity Platform, 128 channel CARTO 3 version 4 with ICE mapping facility, FD 10 Prucka 2D EP system
- High-end Intensive Coronary Care Unit
- Dedicated Pre-Post Cath Unit
- Multislice CT Scan, 1.5 Tesla MRI
- 24 *7*365 functional cardiac Cath lab & operation theatre
- Fifteen bedded Coronary Care Unit
- 3D, 4D Echo & Trans-oesophageal Echo, Non Invasive cardiology (Holter, TMT, Echo, 24hrs ambulatory BP Monitoring
- Radio Frequency Ablation like Complex Arrhythmia such as ischemic VT, AF with 3 D Mapping imaging
- RFA using ICE Intra-cardiac Echo
- Well-equipped inpatient and intensive care services
- Ultra-modern Blood Bank Facility
- Advanced Physiotherapy center, 24/7 Emergency &Trauma services
- Gastroenterology department equipped with Capsule endoscopy, Endoscopic retrograde cholangiopancreatography, Single balloon enteroscopy, High resolution esophageal and anorectal manometry, Endoscopic ultrasound, and hydrogen breath test
Sustained low-efficiency daily dialysis and Continuous Renal Replacement Therapy - Exhaled Nitric oxide (FeNO) and allergy testing for the management of asthma
- Conventional PAP/ Liquid PAP/ HPV-DNA test for the patients with the High risk of cervical cancer
Max Smart Super Speciality Hospital
Delhi, India
- Max Smart Super Speciality Hospital, Saket, New Delhi, is a 250-bed tertiary care hospital known for advanced medical technology and patient-centred care.
- The hospital offers services across 22+ specialities, including Cardiac Sciences, Orthopaedics, Urology, Neurology, Neurosurgery, Paediatrics, Obstetrics, and Gynaecology.
- It is a regional hub for complex procedures such as neurovascular interventions, targeted cancer treatments, heart surgeries, kidney and liver transplants, and bariatric care.
- Equipped with a 3.0 Tesla MRI, 256 Slice CT Angio, Cath Labs, Digital Orthopaedic Suite, and advanced diagnostic tools, and supported by 275+ doctors and 606+ trained staff, Max Smart Saket provides high-quality, multidisciplinary care for domestic and international patients.
Our Services to better your experience
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome
Why Choose India for Dyslipidemia Treatment?
- Experienced Cardiometabolic Specialists: Major Indian hospitals may provide access to cardiologists, endocrinologists, lipid specialists, internal medicine physicians, and other specialists involved in managing complex lipid disorders.
- Advanced Lipid Testing: Many centres offer comprehensive lipid profiles, Lp(a) and apoB testing, metabolic evaluation, and assessment for inherited or secondary causes of dyslipidemia when clinically indicated.
- Modern Cardiovascular Risk Assessment: Selected centres may offer CAC scoring, cardiovascular imaging, advanced risk assessment, and evaluation for established or subclinical cardiovascular disease.
- Comprehensive Treatment Options: Patients may have access to lifestyle programmes, statins, non-statin lipid-lowering medicines, therapies for severe hypertriglyceridemia, and specialist management of familial lipid disorders.
- International Patient Support: Major Indian hospitals may provide medical-record review, specialist coordination, treatment scheduling, visa and travel assistance, accommodation support, interpretation, and follow-up services for international patients.
Frequently Asked Questions
Dyslipidemia generally does not have a fixed recovery period because it is usually a chronic metabolic condition rather than an acute illness. Cholesterol and triglyceride levels may begin to improve within weeks to months after lifestyle changes or medication, but long-term treatment and monitoring may be necessary to maintain lipid control and reduce cardiovascular risk.
Yes. Dyslipidemia itself generally does not interfere with walking. Regular walking and other forms of physical activity can support cardiovascular health and help improve some lipid abnormalities. People with known cardiovascular disease, chest pain, severe breathlessness, or other exercise limitations should discuss an appropriate activity level with their healthcare professional.
Many advanced Indian hospitals provide comprehensive lipid testing, cardiovascular risk assessment, Lp(a) and apoB testing when appropriate, and access to modern lipid-lowering medicines. Selected centres may also offer coronary artery calcium scoring and cardiovascular imaging for patients who require further risk assessment.
Many major Indian hospitals have international-patient departments that may assist with medical records, specialist consultations, treatment coordination, visa documentation, travel arrangements, accommodation, interpretation, and follow-up care. Services vary between hospitals.
Consider a cardiologist, endocrinologist, lipid specialist, or internal medicine physician experienced in managing your specific lipid abnormality and cardiovascular risk profile. For complex or inherited dyslipidemia, consider a centre with access to advanced lipid testing, cardiovascular risk assessment, genetic evaluation when appropriate, and long-term specialist follow-up.
There is no single success rate for dyslipidemia treatment because outcomes depend on the type of lipid abnormality, baseline levels, cardiovascular risk, underlying causes, treatment used, and individual response. Appropriate lifestyle changes and lipid-lowering medicines can substantially reduce LDL-C and other atherogenic lipid levels in suitable patients. The main treatment goal is long-term reduction of cardiovascular risk rather than a single measure of treatment success.
Many tertiary Indian hospitals have cardiologists, endocrinologists, diabetologists, internal medicine physicians, and other specialists experienced in managing dyslipidemia and its associated cardiovascular and metabolic conditions. Patients with familial or complex lipid disorders may benefit from multidisciplinary specialist care.
The risks depend on the treatment used. Statins and other lipid-lowering medicines can cause medication-specific adverse effects, although many patients tolerate them well. Some medicines require monitoring of liver enzymes, kidney function, muscle symptoms, or other parameters depending on the drug. Lifestyle interventions are generally safe when appropriately tailored, while cardiovascular procedures or surgery may have separate procedure-related risks.
Arrange a medical assessment to determine which lipid abnormalities are present and whether they are caused or worsened by conditions such as diabetes, hypothyroidism, kidney disease, liver disease, medications, or an inherited lipid disorder. Discuss your overall cardiovascular risk, appropriate lifestyle changes, and whether lipid-lowering medication is required. If you have very high triglycerides, severe abdominal pain or vomiting requires urgent medical assessment because pancreatitis can occur with severe hypertriglyceridemia.
Dyslipidemia does not generally cause physical deformities. However, severe inherited lipid disorders can sometimes cause visible cholesterol deposits such as tendon xanthomas or xanthelasma. More importantly, prolonged untreated dyslipidemia can contribute to atherosclerosis and cardiovascular complications that may cause long-term disability.
Yes, particularly when dyslipidemia is associated with cardiovascular disease, diabetes, obesity, or other chronic conditions. Dyslipidemia itself is often asymptomatic, but long-term cardiovascular complications can affect physical activity, independence, work, and daily functioning. Effective lipid management can help reduce the risk of these complications.
Yes. Persistently elevated atherogenic lipoproteins can contribute to plaque formation and increase the risk of coronary artery disease, heart attack, stroke, and peripheral artery disease. Severe hypertriglyceridemia can also increase the risk of acute pancreatitis. Risk depends on the lipid abnormality, its duration, and the presence of other cardiovascular risk factors.
Prevention and long-term management include eating a heart-healthy diet, maintaining a healthy body weight, exercising regularly, avoiding tobacco, limiting excess alcohol intake, and managing conditions such as diabetes and hypothyroidism. Regular lipid screening can help identify abnormalities early, particularly in people with a family history or other cardiovascular risk factors.
Dyslipidemia can affect people of all ages, but risk is higher in people with a family history of lipid disorders or premature cardiovascular disease, obesity, physical inactivity, diabetes, hypothyroidism, chronic kidney disease, certain liver conditions, or specific medication exposures. Some inherited disorders, such as familial hypercholesterolemia, can cause very high LDL-C levels from a young age.